Hamid, Amira H.

HRN: 23-95-66  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/26/2023
CEFUROXIME 750MG (VIAL)
10/26/2023
11/01/2023
IV
235mg
Q8
AGE
Waiting Final Action 
10/26/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
10/26/2023
11/01/2023
IV
85mg
Q8
AGE
10/31/2023
CEFTRIAXONE 1G (VIAL)
10/31/2023
11/07/2023
IV
850mg
Q24h
Age With Moderate Dhn, Uti
Waiting Final Action 
11/02/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
11/02/2023
11/05/2023
PO
3.5mL
TID
AGE
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: